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The importance of genetic factors in psychiatric 
disorders
Mental illness continues to incur negative attitudes, often 
characterized by fear, stigma and rejection, but the idea 
that it reflects a ‘weakness of character’ that can be over­
come  by  sheer  willpower  is  increasingly  losing  ground 
[1].  Most  people  now  understand  that  psychiatric  dis­
orders are caused by a sick organ, just like heart disease, 
although in this case the organ happens to be the most 
complex organ we possess, the brain.
Appreciation of the importance of biological factors in 
psychiatric  disorders  has  been  strongly  reinforced  by 
evidence  from  twin  and  family  studies  that  genetic 
variation between individuals has a key role in the risk 
for these disorders. Heritability estimates for cognitive 
disorders,  such  as  schizophrenia,  attention  deficit 
hyperactivity disorder (ADHD) and autism, range from 
50% to 80% [2­6]. For affective disorders, such as major 
depres  sion,  anxiety  disorders  and  substance  abuse, 
estimates range from 40% to 65% [3,7,8]. However, pin­
pointing the actual genetic variants responsible for this 
heritability  has  proven  difficult.  The  most  successful 
gene­finding  approach,  genome­wide  association 
(GWA),  has  uncovered  many  genetic  variants  for 
conditions such as diabetes [9], Crohn’s disease [10] and 
atherosclerotic risk [11,12], but this method has, as yet, 
not been as successful for psychiatric disorders [13]. For 
schizo  phrenia  and  autism  only  a  handful  of  genetic 
variants  have  been  identified  [14­16],  and  there  are 
currently no confirmed genetic variants associated with 
ADHD and depression.
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variants that influence psychiatric disease?
The  difficulty  in  identifying  actual  genetic  variants 
probably relates to the complexity of psychiatric pheno­
types, which in turn reflects the complexity of the brain 
processes that underlie them. To reduce this complexity 
it has been proposed to focus genetic studies on so­called 
brain endophenotypes [2,17­19]. The basic reasoning is 
that  it  may  be  easier  to  detect  the  effect  of  a  genetic 
variant  on  a  more  elementary  neurobiological  trait 
because there may be fewer genetic variants with larger 
effect sizes involved in these traits. An important source 
of  brain  endophenotypes  is  electroencephalography 
(EEG). An EEG signal is recorded non­invasively from 
electrodes placed on the scalp and depicts the ongoing 
electrical activity of the brain. An event­related potential 
(ERP) is the brain’s electrical response to the occurrence 
of a specific event. The event is usually a stimulus ­ a 
word or picture presented on a display ­ but it can also be 
generated  internally,  for  instance  by  the  intention  to 
move a limb. An example of an ERP is the P3, a positive 
wave  that  occurs  about  300  ms  after  a  motivationally 
significant  stimulus.  The  P3  reflects  the  activity  of  the 
locus­coeruleus­norepinephrine  system  [20],  which 
facilitates  the  behavioral  and  cognitive  responses  to 
motivationally  significant  events,  and  it  may  be  the 
central  nervous  system  component  of  the  fight­flight 
response [21].
Can EEG and ERP endophenotypes help identify and 
confirm novel genetic risk factors for psychiatric disease? 
To do so they must, first of all, be predictive of psychiatric 
disorders. There is a huge corpus of literature on the use 
of  EEG  or  ERP  endophenotypes  as  risk  markers  for 
psychiatric disorder. It is impossible to review this corpus 
in  a  few  words  here,  but  two  examples  may  serve  to 
illustrate it. First, frontal asymmetry of EEG α power (FA) 
has been studied extensively as a correlate of individual 
differences  in  emotional  response.  Greater  left  hemi­
spheric activity has been associated with a tendency to 
approach  things  of  interest,  and  greater  right  hemi­
spheric  activity  with  withdrawal­related  tendencies 
[22,23].  Disturbances  in  the  emotional  dimension  of 
approach versus withdrawal have a key role in the liability 
to  develop  psychopathology  such  as  depression  and 
anxiety disorders [24,25], with which the FA has indeed 
been found to be associated [2,26,27]. Second, reduced 
amplitude of the P3 is found in a variety of psychiatric 
and behavioral disorders, but most notably schizophrenia 
[28]  and  alcohol  abuse  [29].  The  reduction  in  P3 
amplitude  reflects  a  genetic  predisposition  for  these 
disorders  rather  than  a  mere  functional  consequence, 
because it does not normalize after successful treatment 
[28] and is also found in unaffected relatives [29]. The 
latter point is important. To tag a relevant part of the 
pathway from genetic variation to psychiatric disorder, 
the  endophenotypes  must  be  heritable  traits  and  their 
heritability  must  arise  partly  from  the  genetic  variants 
that also influence the psychiatric disorder [17].
In the Netherlands Twin Register, we have estimated 
the  heritability  of  a  variety  of  EEG  and  ERP  endo­
phenotypes,  and  similar  work  has  been  undertaken  by 
colleagues from twin registries around the world [30­43]; 
Table  1  illustrates  the  findings  from  these  studies.  A 
striking genetic contribution is found to almost all EEG 
and ERP traits. Resting EEG power is even among the 
most  heritable  traits  in  humans.  This  high  heritability 
does not simply reflect ‘trivial’ heritable similarities in the 
composition of the skull or other tissue layers between 
electrode  and  brain.  Almost  identical  heritability 
Table 1. Heritability estimates for EEG/ERP traits*
  Heritability 
EEG/ERP trait  estimates  References
Power α band  86-96%  [30-32]
Power θ band  80-90%  [30,32]
Power β band  70-82%  [30,32]
Peak frequency α band  71-83%  [33,34] 
Path length α band  48-68%  [31]
Cluster coefficient β band  25-40%  [31]
Path length β band  29-42%  [31]
Cluster coefficient α band  37-45%  [31]
Long range temporal correlations α band  47%  [35]
Long range temporal correlations β band  42%  [35]
Frontal EEG asymmetry α band   1-37%  [36]
P50 amplitude attenuation   34%  [47]
N1 amplitude attenuation   45%  [47]
P2 amplitude attenuation   54%  [47]
Mismatch negativity  58%  [37]
Posterior N1 amplitude   50%  [38]
Posterior N1 latency  45%  [38]
Anterior N1 amplitude  22%  [38]
Anterior N1 latency  43%  [38]
Go/Nogo difference N2 amplitude  53%  [39]
Error positivity  52%  [40]
Error-related negativity  47%  [40]
P3 amplitude   50-80%  [37,41,42] 
P3 latency   38-50%  [37,41,42]
Onset lateralized readiness potential  54-62%  [43] 
Peak lateralized readiness potential latency  38-45%  [43] 
*Data are from studies comparing the resemblance in monozygotic twins 
with that in dizygotic twins. If a measure was available at multiple electrodes, 
the electrodes with highest amplitude were selected. A range of heritabilities 
reflects either the variation in estimates across multiple studies or across 
multiple age groups within a single study.
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signals from magnetoencephalography, which are almost 
undistorted by tissues covering the brain [44,45].
To return to the question of whether these heritable 
EEG and ERP endophenotypes can help to identify and 
confirm  novel  genetic  risk  factors  for  psychiatric 
disorders: GWA has been the most successful method for 
detecting  novel  potential  genetic  variants  for  complex 
traits. However, it has a limited ability to detect common 
variants with very small effect sizes and also rare variants 
with very low allele frequencies. Both limitations can be 
tackled by increasing the size of the (pooled) samples, 
although  the  second  also  needs  increased  depth  of 
coverage  of  genomic  variation,  perhaps  even  by  full 
sequen  cing. Unfortunately, the clear need for very large 
sample sizes in GWA studies strongly limits the useful­
ness  of  EEG/ERP  measurements  in  the  gene  discovery 
phase.  EEG/ERP  measurements  require  controlled 
laboratory  experiments  with  sophisticated  and  rather 
expensive  equipment.  They  take  up  to  at  least  20  to 
30 minutes and this may increase up to hours if error 
measurement is to be contained using the more complex 
derived measures [31]. Measuring EEG/ERP, in short, is 
too  hard  to  do  on  the  tens  of  thousands  of  subjects 
needed in a GWA, particularly when contrasted with the 
use  of  existing  patient  records  or  questionnaire­based 
assessment of psychiatric symptoms.
Endophenotypes can help us make sense of 
genetic variants influencing psychiatric disorders
The real value of brain endophenotypes may come after 
gene finding, when they help us confirm the biological 
meaning of the genetic variants that were detected using 
GWA on psychiatric symptoms and diagnoses. One of 
the lessons of successful GWA studies in other fields is 
that  they  point  us  to  genetic  pathways  that  were  not 
previously  known  to  be  involved  in  the  trait.  Finding 
genetic variants for psychiatric symptoms and diagnoses 
needs, therefore, to be followed up by an understanding 
of what these ‘psychiatric’ genes do in the brain. Testing 
the  association  of  the  risk  alleles  with  EEG  and  ERP 
endophenotypes  can  help  us  understand  where  in  the 
brain,  in  which  stage,  and  during  what  type  of 
information  processing  the  genetic  variant  has  a  role. 
Such testing can be done in more modest samples, which 
are more feasible for EEG research.
Could EEG and ERP endophenotypes be more widely 
applied, apart from helping us to understand how genetic 
variants  cause  psychiatric  risk?  The  main  system  for 
classifying  psychiatric  disorders  is  the  Diagnostic  and 
Statistical  Manual  of  Mental  Disorders  (DSM­V).  This 
system is based on a tally of symptoms and their impact 
on  daily  functioning  reported  by  patients  or  their 
caregivers. The DSM currently is undergoing substantial 
revision [46], and a question that repeatedly surfaces is 
whether  we  can  use  the  combination  of  genetic  risk 
scores and brain endophenotypes to better classify psy­
chiatric disorders. Progress in research on the genetics of 
brain  endophenotypes  may  be  key  to  the  successful 
development of such a classification system. This system 
would  base  our  diagnostic  procedures  more  solidly  on 
biology  and  reinforce  the  notion  that  psychiatric 
disorders are disorders of the brain.
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